Intensity Therapeutics Statistics

Total Valuation

INTS has a market cap or net worth of $38.89 million. The enterprise value is $39.80 million.

Market Cap	38.89M
Enterprise Value	39.80M

Important Dates

The next estimated earnings date is Thursday, March 13, 2025, after market close.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

INTS has 15.10 million shares outstanding. The number of shares has increased by 128.09% in one year.

Current Share Class	15.10M
Shares Outstanding	15.10M
Shares Change (YoY)	+128.09%
Shares Change (QoQ)	+0.67%
Owned by Insiders (%)	26.07%
Owned by Institutions (%)	11.54%
Float	6.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.77
P/TBV Ratio	15.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.05.

Current Ratio	1.63
Quick Ratio	1.20
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -173.99% and return on invested capital (ROIC) is -110.15%.

Return on Equity (ROE)	-173.99%
Return on Assets (ROA)	-94.96%
Return on Capital (ROIC)	-110.15%
Revenue Per Employee	n/a
Profits Per Employee	-$2.32M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.02%
50-Day Moving Average	2.50
200-Day Moving Average	3.85
Relative Strength Index (RSI)	58.51
Average Volume (20 Days)	49,232

Short Selling Information

The latest short interest is 38,925, so 0.26% of the outstanding shares have been sold short.

Short Interest	38,925
Short Previous Month	62,208
Short % of Shares Out	0.26%
Short % of Float	0.58%
Short Ratio (days to cover)	3.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.73M
Pretax Income	-15.07M
Net Income	-16.26M
EBITDA	n/a
EBIT	-16.73M
Earnings Per Share (EPS)	-$1.18

Full Income Statement

Balance Sheet

The company has $2.78 million in cash and $145,000 in debt, giving a net cash position of $2.64 million or $0.17 per share.

Cash & Cash Equivalents	2.78M
Total Debt	145,000
Net Cash	2.64M
Net Cash Per Share	$0.17
Equity (Book Value)	2.78M
Book Value Per Share	0.20
Working Capital	1.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-13.50M
Capital Expenditures	n/a
Free Cash Flow	-13.50M
FCF Per Share	-$0.89

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-128.09%
Shareholder Yield	-128.09%
Earnings Yield	-38.32%
FCF Yield	-31.81%

Analyst Forecast

The average price target for INTS is $8.50, which is 230.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	230.10%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1